VCEL
Vericel Corporation
NASDAQ · Healthcare · Biotechnology · US
$40.19
−0.69%Margins
Gross margin
74.6%
EBITDA margin
12.6%
EBIT margin
6.0%
Net margin
7.9%
FCF margin
16.2%
6.5%
Return on equity
4.8%
Return on assets
3.9%
Return on invested capital
0.62x
Asset turnover
$69.7M
Cash from operations
$3.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026